teva pharmaceuticals introduces the first generic glp-1 for weight loss Wegovy Pill Wins FDA Approval as Oral Treatment Obesity and Teva Launches First Generic GLP-1

The gasses from the small bowel bacteria may be detected in the breath

Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S

A 150lb individual and a 250lb individual should not use identical doses and expect equivalent results

blend: 3000mg L-Citrulline Malate

MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed

Certain peptides help regulate the bodys circadian rhythm, ensuring deeper and more restorative sleep